CTSE 2012 conference to showcase potential of clinical trial scenario in Southeast Asia

A conference on Clinical Trials in Southeast Asia (CTSE 2012) will be held in Mumbai on November 23, 2012.

The conference, to be held in Hotel Sahara Star, Mumbai, will showcase the potential of clinical trial scenario in Southeast Asia.

The regulatory agencies, their expectations and their process for approvals are some of the key points in this conference.

Delegates include directors, VPs, senior medical advisors and senior staff of regulatory affairs from pharma and biotech companies and also couple of clinical research organisations as solution providers with expertise in this region.

Indian and multinational big pharma and biotech companies are taking their trials to Southeast Asia due to stringent regulatory approvals and increase in denials for conducting clinical trials in India.

The conference advisory board and the speaker faculty are leading experts from the region, with hands-on experience in clinical trials in Southeast Asia.

The agenda tackles the key strategic, regulatory and scientific issues impacting the industry today as well as perspectives about the future. Express Pharma is the media partner for the event.

Delegate invitees to CTSE 2012 include decision-makers and influencers from big pharma, early stage and mid stage biotechs, government and regulatory bodies.

The organiser’s database includes the details of almost all companies that have ever conducted clinical trials in Asia.

EP News Bureau